The Aβ42/Aβ40 ratio in plasma is associated with amyloid‐PET status and rate of progression in individuals with subjective cognitive decline: The Fundació ACE Healthy Brain Initiative

Authors :: Oscar Sotolongo-Grau
Mercè Boada
Marta Marquié
Judith Romero
Noelia Fandos
Angela Sanabria
Manuel Sarasa
Itziar de Rojas
Pedro Pesini
Juan Pablo Tartari
Agustín Ruiz
Source :: Alzheimer's & Dementia. 16
Publication Year :: 2020
Publisher :: Wiley, 2020.

Subjects :: Oncology
medicine.medical_specialty
Epidemiology
business.industry
Health Policy
Amyloid pet
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Internal medicine
medicine
Neurology (clinical)
Geriatrics and Gerontology
Cognitive decline
business

Tools